https://www.selleckchem.com/pr....oducts/napabucasin.h
Post-eGFR was positively associated with gestational week and birth weight. However, the cumulative GH dose was not correlated with pre-eGFR, post-eGFR or percent change in eGFR (%ΔeGFR). The change in body weight-standard deviation score during GH treatment was positively correlated with %ΔeGFR in the ELBW group. The current results indicated that GH treatment was unlikely a risk for the reduction in eGFR in short-statured children born SGA. However, eGFR should be carefully monitored especially in those born SGA with ELBW because
Like
Comment
Share
